Area of research
Epidemiology · Hepatology
Research interest
Research interests include Medicine, Fibrosis, Internal medicine, Fatty liver, Alcoholic liver disease, and Chronic hepatitis.
Prospective multicentre randomised controlled trial to assess the clinical effectiveness of the novel CirrhoCare digital therapeutic management system: a study protocol
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
The macrophage activation marker <scp>sCD</scp>163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease
Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury
Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C